Clinical Trials Browser

Disease Progression × carotuximab × Clear all

NCT01778530 2015-10-07

TRC105 for Recurrent Glioblastoma

Phase 2 Terminated

2 enrolled 9 charts

Glioblastoma, Glioma, Disease Progression